Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll

January 16, 2012

U.K. Biotech Strategy

Intent on shepherding more biopharma companies to market and keeping them growing, Prime Minister David Cameron recently unveiled a “Strategy for UK Life Sciences”. The strategy calls for the U.K. to launch a £180 million ($278.6 million) fund to push startup companies past the “valley of death,” a £130 million ($201.2 million) personalized medicine research fund, and a £50 million ($77.4 million) cell therapy technology center, among other components. The strategy also promises a new initiative to speed up approvals of new drugs. “We must ensure that the U.K. stays ahead,” Cameron said. Do you think the Strategy will help the U.K. reach its goals for biotechnology?

How much do you think the new Strategy will succeed in enhancing the U.K.’s competitiveness in biopharma?

  {{ choice.Percent }}%